Considerations in the Diagnosis and Management of Pulmonary Hypertension Associated With Left Heart Disease
JACC: Heart Failure · 2024
DOI: 10.1016/j.jchf.2024.04.031 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JACC: Heart Failure, 2024. Verfasst von Onyedika J Ilonze und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University, Indianapolis, Indiana, USA. Electronic address: oil…. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Heart Failure. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Indiana University School of Medicine.
Abstract (Originalsprache)
Pulmonary hypertension associated with left heart disease (PH-LHD) remains the most common cause of pulmonary hypertension globally. Etiologies include heart failure with reduced and preserved ejection fraction and left-sided valvular heart diseases. Despite the increasing prevalence of PH-LHD, there remains a paucity of knowledge about the hemodynamic definition, diagnosis, treatment modalities, and prognosis among clinicians. Moreover, clinical trials have produced mixed results on the usefulness of pulmonary vasodilator therapies for PH-LHD. In this expert review, we have outlined the critical role of meticulous hemodynamic evaluation and provocative testing for cases of diagnostic uncertainty. Therapeutic strategies-pharmacologic, device-based, and surgical therapies used for managing PH-LHD-are also outlined. PH-LHD in advanced heart failure, and the role of mechanical circulatory support in PH-LHD is briefly explored. An in-depth understanding of PH-LHD by all clinicians is needed for improved recognition and outcomes among patients with PH-LHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University, Indianapolis, Indiana, USA. Electronic address: oilonze@iu.edu.
- Division of Cardiology, University of California Davis, Sacramento, California, USA.
- Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University, Indianapolis, Indiana, USA.
- Winters Center for Heart Failure Research, Michael E. DeBakey VA Medical Center, Texas Heart Institute, Baylor College of Medicine, Houston, Texas, USA.
- Division of Cardiology, Bluhm Cardiovascular Institute Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- University of Michigan Hospital and Health Systems, Ann Arbor, Michigan, USA.
Förderung
- Indiana University School of Medicine
Zitieren
APA
Ilonze, O. J., Ebong, I. A., Guglin, M., Nair, A., Rich, J., McLaughlin, V., Tedford, R. J., & Mazimba, S. (2024). Considerations in the Diagnosis and Management of Pulmonary Hypertension Associated With Left Heart Disease. JACC: Heart Failure. https://doi.org/10.1016/j.jchf.2024.04.031
Vancouver
Ilonze OJ, Ebong IA, Guglin M, Nair A, Rich J, McLaughlin V, et al. Considerations in the Diagnosis and Management of Pulmonary Hypertension Associated With Left Heart Disease. JACC: Heart Failure. 2024. doi:10.1016/j.jchf.2024.04.031
BibTeX
@article{Ilonze2024,
author = {Ilonze, Onyedika J and Ebong, Imo A and Guglin, Maya and Nair, Ajith and Rich, Jonathan and McLaughlin, Vallerie and Tedford, Ryan J and Mazimba, Sula},
title = {Considerations in the Diagnosis and Management of Pulmonary Hypertension Associated With Left Heart Disease},
journal = {JACC: Heart Failure},
year = {2024},
doi = {10.1016/j.jchf.2024.04.031}
}
EUVIMED